|
|
| Line 88: |
Line 88: |
| | | | |
| | <hr width="100%" > | | <hr width="100%" > |
| − | <h6><font size="4" face="Century"> developing the efficiency of circularization </font><br></h6> | + | <h6><font size="5" face="Century"> developing the efficiency of circularization </font><br></h6> |
| | <font size="3" face="Arimo"> | | <font size="3" face="Arimo"> |
| − | <b><li>About the complementary sequences at outside of both splicing sites</li></b><br> | + | <b>About the complementary sequences at outside of both splicing sites</b><br> |
| − | <p> In last year, we made a circular part by cloning splicing site from an intron of T4phage. There are the complementary sequences inside the splicing site in this intron. We thought that the sequence brings one splicing site close to the other one and ensures the reaction takes place.<br> | + | <p> In last year, we made a circular part by cloning splicing site from an intron of T4phage. There are the complementary sequences inside the splicing site in this intron. We thought that the sequence brings one splicing site close to the other one and ensures the reaction takes place.<br></p> |
| − | So, we cloned splicing sites with complementary sequences in intron and made it into parts. Moreover, we made the device which express circular mRNA by using this part, and made its express in <i>E.coli</i>. Then, complementary sequences are included in outside of both splicing sites in RNA. | + | <p> So, we cloned splicing sites with complementary sequences in intron and made it into parts. Moreover, we made the device which express circular mRNA by using this part, and made its express in <i>E.coli</i>. Then, complementary sequences are included in outside of both splicing sites in RNA. |
| | </p> | | </p> |
| | | | |
Revision as of 00:33, 16 September 2015
|
|
PROJECT
EXPERIMENTS
Making functional long chain protein
In our last study, our long protein lost its function. As the reason, we had an idea that the protein lost its holding structure because it was much longer. So, we aimed to synthesize functional long chain proteins by designing some linkers in this year.
The requirements for amino acids that con be the linkers are less of steric effects and strong in hydropathy. Glycine and serine fulfill this requirements. Glycine’ side chain has almost no steric effects. On the other hand, serine has some steric effects but it has powerful hydropathy because of its hydroxyl side chain. According to やべっち, because histidine has quite strong hydropathy, though it has big steric effects, it is possible that histidine can work as linker.
Amino acid chains synthesized from circular messenger RNA are constructed from repetition in amino acid of target protein, amino acid from ribozyme and amino acid from RBS. In this experiment, we inserted linker sequences into inside of both splicing sites. So, protein chains synthesized from circular messenger RNA that include linker sequences repeat linker sequence, amino acid from RBS, target protein, linker sequence and amino acid from ribozyme.
Generally speaking, length of linker is required of one-forth of diameter of target protein. In the case of RFP, that condition is surely cleared by six amino acid, but it is unknown which linkers are appropriate in order to synthesize poly RFP protein. Therefore, we examine some types of amino acids and length of linker and choice the best linker in this experiment.
developing the efficiency of circularization
About the complementary sequences at outside of both splicing sites
In last year, we made a circular part by cloning splicing site from an intron of T4phage. There are the complementary sequences inside the splicing site in this intron. We thought that the sequence brings one splicing site close to the other one and ensures the reaction takes place.
So, we cloned splicing sites with complementary sequences in intron and made it into parts. Moreover, we made the device which express circular mRNA by using this part, and made its express in E.coli. Then, complementary sequences are included in outside of both splicing sites in RNA.
|